Whole body planar and 3D quantitative imaging after 177Lu-DOTATATE on CZT SPECT/CT device with MEHRS collimator. First report. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Hellenic journal of nuclear medicine Année : 2021

Whole body planar and 3D quantitative imaging after 177Lu-DOTATATE on CZT SPECT/CT device with MEHRS collimator. First report.

Résumé

Lutetium-177 (177Lu)-based post-therapeutic imaging allows visualization of treated lesions andabsorbed dose measurement. There is an increasing number of cadmium-zinc-telluride (CZT) gamma-cameras in nuclear medicine departments but until now these devices were not adapted to the medium-energy emission of 177Lu photons. We present here in the first reported images acquired with a new collimator designed for CZT gamma-camera compared to a conventional sodium iodide (NaI) (Tl) gamma-camera. Post-therapeutic 177Lu-DOTATATE imaging on a CZT device with a medium energy high resolution (MEHRS)-collimator are promising and support the widespread of both 177Lu-based peptide-receptor radionuclide therapy (PRRT) and CZT gamma-cameras.
Fichier non déposé

Dates et versions

hal-03631031 , version 1 (05-04-2022)

Identifiants

Citer

Emmanuel Deshayes, Cyril Fersing, Kévin Hébert, Manuel Bardies, Pierre-Olivier Kotzki, et al.. Whole body planar and 3D quantitative imaging after 177Lu-DOTATATE on CZT SPECT/CT device with MEHRS collimator. First report.. Hellenic journal of nuclear medicine, 2021, 24 (2), pp.165-166. ⟨10.1967/s002449912361⟩. ⟨hal-03631031⟩
37 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More